Evidence map›Paper›PMID 42680804›Full record

ArticleScientific reports2026

Comprehensive proximity proteomics expand the known interactome of the oncoprotein β-catenin.

Lavanya Moparthi, Wenjing Zhong, Stefan Koch

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lavanya MoparthiDepartment of Biomedical and Clinical Sciences (BKV), BKV/MMV, Linköping University, Plan 13, Lab 1, 58185, Linköping, Sweden. Lavanya.moparthi@liu.se.
Wenjing ZhongDepartment of Biomedical and Clinical Sciences (BKV), BKV/MMV, Linköping University, Plan 13, Lab 1, 58185, Linköping, Sweden.
Stefan KochDepartment of Biomedical and Clinical Sciences (BKV), BKV/MMV, Linköping University, Plan 13, Lab 1, 58185, Linköping, Sweden. Stefan.koch@liu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oncoprotein β-catenin has critical roles in cell adhesion and cell signalling. β-catenin affects human physiology and pathology through numerous interaction partners, of which many have been discovered by standard affinity purification-based proteomics. However, the interaction landscape of β-catenin remains incompletely understood, highlighting a need for new experimental approaches for the exploration of β-catenin biology. Proximity proteomics, which facilitate the discovery of molecules vicinal to proteins-of-interest by mass spectrometry, have recently emerged as a powerful complementary tool for the study of protein-protein interactions, but have not been applied to β-catenin so far. We investigated the interactome of β-catenin in model cell lines by proximity proteomics using expression constructs with the biotin ligases BioID and TurboID. Mass spectrometry analyses following biotin labelling identified numerous candidate interactors of β-catenin, including many that had not been observed in earlier studies using standard proteomics. Enrichment analyses suggested that proximity proteomics capture proteins associated with the known biological functions of β-catenin, including cell adhesion, Wnt/β-catenin signalling, and transcription regulation. The molecular tools and data generated in this study provide new insights into β-catenin biology and highlight potential new regulators of β-catenin function that warrant further exploration.

Indexed as

beta CateninProteomicsCell AdhesionHumansMass SpectrometryProtein BindingProtein Interaction MappingProtein Interaction MapsWnt Signaling Pathwaybeta CateninBioIDMass spectrometryProteomicsTurboIDβ-catenin

Identifiers

PMID42680804
PMCPMC13534447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.